India

Clinical trials in India also growing at a higher rate, and the country is now in fourth place for COVID-19 trials

Roche and Cipla had previously entered into a similar agreement in February 2018 for promotion and distribution of Tocilizumab…

Gilead’s three patents in India for remdesivir stem from 2009 when the drug was in development to treat Ebola

He also stated that India has an important role to play in these times of crisis as a global supplier of medicines

Recent clinical trial results and the decision by the US Food and Drug Administration (FDA) to issue ''Emergency Use…

Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China

Domestic pharma cos expected to grow at a CAGR of around 10-12 per cent between FY2019-2022 ICRA has maintained a stable…

The move adds to the company's further expansion of global network in the Asia Pacific region

The agreement will provide structured framework for cooperation between the two countries on medicinal plants

The MoU was signed on 02nd August, 2019 during the three-day visit of the President Ram Nath Kovind to Guinea